Download Files:
BGG463
$71 – $950
Products Details
Product Description
– BGG463 (K03859) is an orally active type II CDK2 inhibitor[1].
Web ID
– HY-100600
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C30H29F3N6O3
References
– [1]Alexander LT, et al. Type II Inhibitors Targeting CDK2. ACS Chem Biol. 2015 Sep 18;10(9):2116-25.|[2]Jones K, et al. Cancer Drug Discovery 2010: from molecules to medicine. Expert Rev Clin Pharmacol. 2010 Sep;3(5):613-5.
CAS Number
– 890129-26-7
Molecular Weight
– 578.58
Compound Purity
– 98.0
SMILES
– O=C(C1=C2C=CC(OC3=NC=NC(NC(C)=O)=C3)=CC2=CC=C1)NC4=CC=C(CN5CCN(C)CC5)C(C(F)(F)F)=C4
Clinical Information
– No Development Reported
Research Area
– Others
Solubility
– DMSO : ≥ 125 mg/mL
Target
– CDK
Isoform
– CDK2
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.